James Gallarda

815 total citations
17 papers, 655 citations indexed

About

James Gallarda is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, James Gallarda has authored 17 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Epidemiology and 6 papers in Hepatology. Recurrent topics in James Gallarda's work include Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and SARS-CoV-2 detection and testing (3 papers). James Gallarda is often cited by papers focused on Hepatitis B Virus Studies (6 papers), Hepatitis C virus research (6 papers) and SARS-CoV-2 detection and testing (3 papers). James Gallarda collaborates with scholars based in United States, Canada and Poland. James Gallarda's co-authors include Kevin P. Foley, James Douglas Engel, Michael P. Busch, Steven Kleinman, Elizabeth A. Dragon, Richard Smith, Cristina Giachetti, Dale F. Hirschkorn, Simone A. Glynn and Yongling Tu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Genes & Development and The Journal of Immunology.

In The Last Decade

James Gallarda

17 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Gallarda United States 13 249 236 196 182 94 17 655
James H. McLinden United States 19 299 1.2× 364 1.5× 173 0.9× 170 0.9× 248 2.6× 39 781
Élodie Beaumont France 13 343 1.4× 337 1.4× 90 0.5× 124 0.7× 163 1.7× 22 776
Dale F. Hirschkorn United States 15 296 1.2× 199 0.8× 96 0.5× 218 1.2× 202 2.1× 19 880
Raphaële Germi France 15 394 1.6× 155 0.7× 63 0.3× 317 1.7× 47 0.5× 49 870
Liam J. Fanning Ireland 20 564 2.3× 684 2.9× 190 1.0× 108 0.6× 127 1.4× 57 1.1k
Sherrol H. McDonough United States 11 400 1.6× 127 0.5× 162 0.8× 127 0.7× 114 1.2× 11 560
E Ben‐Porath Israel 13 675 2.7× 574 2.4× 94 0.5× 204 1.1× 28 0.3× 33 954
Christiane Brohm Germany 7 403 1.6× 439 1.9× 110 0.6× 174 1.0× 71 0.8× 7 674
Christine Defer France 12 258 1.0× 227 1.0× 185 0.9× 234 1.3× 61 0.6× 19 681
Catharina Hultgren Sweden 14 485 1.9× 452 1.9× 109 0.6× 232 1.3× 207 2.2× 30 857

Countries citing papers authored by James Gallarda

Since Specialization
Citations

This map shows the geographic impact of James Gallarda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Gallarda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Gallarda more than expected).

Fields of papers citing papers by James Gallarda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Gallarda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Gallarda. The network helps show where James Gallarda may publish in the future.

Co-authorship network of co-authors of James Gallarda

This figure shows the co-authorship network connecting the top 25 collaborators of James Gallarda. A scholar is included among the top collaborators of James Gallarda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Gallarda. James Gallarda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Cantera, Jason L., Maureen H. Diaz, Jonas M. Winchell, et al.. (2019). Performance and workflow assessment of six nucleic acid extraction technologies for use in resource limited settings. PLoS ONE. 14(4). e0215753–e0215753. 12 indexed citations
2.
Cantera, Jason L., Maureen H. Diaz, Jonas M. Winchell, et al.. (2019). Assessment of eight nucleic acid amplification technologies for potential use to detect infectious agents in low-resource settings. PLoS ONE. 14(4). e0215756–e0215756. 32 indexed citations
3.
Busch, Michael P., Simone A. Glynn, David J. Wright, et al.. (2005). Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion. 45(12). 1853–1863. 35 indexed citations
4.
Glynn, Simone A., David J. Wright, Steven Kleinman, et al.. (2005). Dynamics of viremia in early hepatitis C virus infection. Transfusion. 45(6). 994–1002. 160 indexed citations
5.
Busch, Michael P., Leslie H. Tobler, J. Saldanha, et al.. (2005). Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003. Transfusion. 45(4). 492–499. 39 indexed citations
6.
Tobler, Leslie H., Celso Bianco, Sharon A. Glynn, et al.. (2005). Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic. Transfusion. 45(4). 480–486. 16 indexed citations
7.
Tobler, Leslie H., Celso Bianco, Sharon A. Glynn, et al.. (2005). Detection of WNV RNA in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic. 1 indexed citations
8.
Asmuth, David M., Leslie A. Kalish, Megan E. Laycock, et al.. (2003). Absence of HBV and HCV, HTLV‐I and ‐II, and human herpes virus‐8 activation after allogeneic RBC transfusion in patients with advanced HIV‐1 infection. Transfusion. 43(4). 451–458. 6 indexed citations
9.
Operskalski, Eva A., James W. Mosley, Leslie H. Tobler, et al.. (2003). HCV viral load in anti‐HCV‐reactive donors and infectivity for their recipients. Transfusion. 43(10). 1433–1441. 30 indexed citations
10.
Galel, Susan A., et al.. (2002). Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays. Transfusion. 42(11). 1507–1513. 22 indexed citations
11.
Gallarda, James & Elizabeth A. Dragon. (2000). Blood Screening by Nucleic Acid Amplification Technology: Current Issues, Future Challenges. Molecular Diagnosis. 5(1). 11–22. 41 indexed citations
12.
Gallarda, James, et al.. (2000). Blood screening by nucleic acid amplification technology: Current issues, future challenges. Molecular Diagnosis. 5(1). 11–22. 1 indexed citations
13.
14.
Gallarda, James, et al.. (1989). The beta-globin stage selector element factor is erythroid-specific promoter/enhancer binding protein NF-E4.. Genes & Development. 3(12a). 1845–1859. 110 indexed citations
15.
Gallarda, James, et al.. (1988). Partial molecular genetic map of the rabbit VH chromosomal region.. The Journal of Immunology. 140(5). 1651–1659. 45 indexed citations
16.
Yew, Nelson S., et al.. (1987). Expression of cytoskeletal protein 4.1 during avian erythroid cellular maturation.. Proceedings of the National Academy of Sciences. 84(4). 1035–1039. 15 indexed citations
17.
Gallarda, James, et al.. (1985). Organization of rabbit immunoglobulin genes. I. Structure and multiplicity of germ-line VH genes.. The Journal of Immunology. 135(6). 4222–4228. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026